CN114806920A - Culture medium of bifidobacterium as well as culture method and application thereof - Google Patents
Culture medium of bifidobacterium as well as culture method and application thereof Download PDFInfo
- Publication number
- CN114806920A CN114806920A CN202210186252.2A CN202210186252A CN114806920A CN 114806920 A CN114806920 A CN 114806920A CN 202210186252 A CN202210186252 A CN 202210186252A CN 114806920 A CN114806920 A CN 114806920A
- Authority
- CN
- China
- Prior art keywords
- bifidobacterium
- culture medium
- parts
- bifidobacteria
- culturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186000 Bifidobacterium Species 0.000 title claims abstract description 108
- 239000001963 growth medium Substances 0.000 title claims abstract description 63
- 238000012136 culture method Methods 0.000 title abstract description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 26
- 229920001202 Inulin Polymers 0.000 claims abstract description 25
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 25
- 229940029339 inulin Drugs 0.000 claims abstract description 25
- 239000001814 pectin Substances 0.000 claims abstract description 25
- 229920001277 pectin Polymers 0.000 claims abstract description 25
- 235000010987 pectin Nutrition 0.000 claims abstract description 25
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 22
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 21
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 21
- 150000002148 esters Chemical class 0.000 claims abstract description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 6
- 241001052560 Thallis Species 0.000 claims abstract description 5
- 239000002537 cosmetic Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
- 238000012258 culturing Methods 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 33
- 239000012137 tryptone Substances 0.000 claims description 25
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- 230000012010 growth Effects 0.000 claims description 16
- 230000001502 supplementing effect Effects 0.000 claims description 14
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 12
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 12
- 229940099596 manganese sulfate Drugs 0.000 claims description 12
- 239000011702 manganese sulphate Substances 0.000 claims description 12
- 235000007079 manganese sulphate Nutrition 0.000 claims description 12
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 10
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 9
- 239000001110 calcium chloride Substances 0.000 claims description 9
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 9
- 235000011148 calcium chloride Nutrition 0.000 claims description 9
- 239000011790 ferrous sulphate Substances 0.000 claims description 7
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 7
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 7
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims 3
- 239000007624 bifidobacterium medium Substances 0.000 claims 1
- 229920002601 oligoester Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 230000035755 proliferation Effects 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000009044 synergistic interaction Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 24
- 241000894006 Bacteria Species 0.000 description 18
- 239000000306 component Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000012840 feeding operation Methods 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- WHWDWIHXSPCOKZ-UHFFFAOYSA-N hexahydrofarnesyl acetone Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)=O WHWDWIHXSPCOKZ-UHFFFAOYSA-N 0.000 description 4
- 229940040511 liver extract Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 235000019797 dipotassium phosphate Nutrition 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- -1 0.15g/L Chemical compound 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- JBJWASZNUJCEKT-UHFFFAOYSA-M sodium;hydroxide;hydrate Chemical compound O.[OH-].[Na+] JBJWASZNUJCEKT-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000009270 zilongjin Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a culture medium of bifidobacterium, a culture method and application thereof, wherein the culture medium of bifidobacterium comprises a carbon source, a nitrogen source, inorganic salt and prebiotics; the prebiotics include fructooligosaccharides, low ester pectins, and inulin. The invention creatively combines fructo-oligosaccharide, low-ester pectin and inulin as prebiotic components to be added into a bifidobacterium culture medium, and the three components are mutually matched to realize synergistic interaction, thereby having unexpected synergistic interaction effect on the aspects of promoting the proliferation of bifidobacterium and improving the yield of thalli. Compared with the commercial culture medium, the bifidobacterium culture medium provided by the invention has a remarkable proliferation promoting effect on bifidobacterium, and has an important application value in the fields of food, medicines or cosmetics.
Description
Technical Field
The invention belongs to the technical field of microbial culture, and relates to a culture medium of bifidobacterium, a culture method and application thereof.
Background
Bifidobacteria, which were originally isolated from the feces of breast-fed infants by Henry Tissier in 1899, are physiological bacteria beneficial to the body, have nutritional and health-care functions, and serve as important physiological bacteria in the human intestinal tract, and the presence and amount of the bifidobacteria are important markers of human health.
The bifidobacterium can provide various nutrient components including lactic acid, acetic acid, vitamins, protease and the like for the intestinal tract of a host, can improve the pH value of the organism and promote the organism to absorb metal ions such as phosphorus, iron, calcium and the like, vitamins and proteins; the bifidobacteria can compete for nutrients and spatial positions with pathogenic bacteria, and can prevent the growth of the pathogenic bacteria through metabolites of the bifidobacteria and production of antibiotics, bacteriocins and the like; the bifidobacterium has the function of immunoregulation, and can stimulate and activate the immune system to generate antibodies and cytokines, thereby better improving the immunity and anti-infection capability of the human body; the bifidobacterium can obviously increase the content and the biological activity of superoxide dismutase in blood, effectively promote the elimination of free radicals in organisms, reduce the toxicity of harmful substances in the organisms by 90 percent, inhibit the peroxidation of plasma lipid and have the effect of resisting the aging of the organisms.
After the newborn is born for hours, the bifidobacteria can be planted in the intestinal tract, however, due to the reasons of age increase, the use of antibiotics, environmental factors and the like, the quantity of the bifidobacteria in the intestinal tract of the human body is gradually reduced, so that the microbial ecological balance in the intestinal tract is caused, and various diseases or aging are caused. Therefore, the bifidobacterium is often used as a core component of a live bacterial preparation and is widely applied to the markets of medical treatment and health care. In recent years, studies have been made on the action of bifidobacterium, and it has been found that bifidobacterium has a function of promoting DNA repair after ultraviolet irradiation, a function of repairing skin barrier and protecting skin against photoaging caused by ultraviolet, and thus it is also very popular in the daily chemical market such as cosmetics, and the demand for bifidobacterium in the market is further increasing.
However, bifidobacterium belongs to obligate anaerobe, is very sensitive to oxygen, has poor tolerance to low pH and is extremely easy to inactivate, and the bifidobacterium has short life span and is difficult to preserve seeds.
For example, CN108085264A discloses an improved bifidobacterium tomato medium and a preparation method thereof. Wherein each liter of bifidobacterium tomato culture solution contains the following components: 9-10g of molasses, 89g of corn flour, 1.00-1.50mL of isomalto-oligosaccharide, 0.4-0.6g of potassium hydrogen phosphate, 0.0050.007 g of manganese sulfate and 1L of tomato juice basic culture medium. The improved bifidobacterium tomato culture medium has the advantages of short culture time, good activity, low cost, simple preparation method and operation, and the like.
CN109112089A discloses a subculture method for increasing the culture concentration of bifidobacterium. The invention finds the growth inertia of the bifidobacterium, improves the concentration of the viable cells by more than 10 times through a characteristic subculture scheme, has important values for preparing high-concentration bifidobacterium leavening agent and probiotic preparation and popularizing and applying the same, has important significance for meeting the requirements of people on high-quality food, and has good social and economic benefits for popularizing and applying the same.
However, the methods for culturing bifidobacteria provided by the prior art still have the problems of slow growth rate and low yield of bifidobacteria, and are difficult to be used for industrial production. Therefore, the development of a method for culturing bifidobacterium, which can increase the growth rate and yield of bifidobacterium, is a problem to be solved by those skilled in the art.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a culture medium of mycobacterium as well as a culture method and application thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a bifidobacterium culture medium comprising a carbon source, a nitrogen source, inorganic salts and prebiotics;
the prebiotics include fructooligosaccharides, low ester pectins, and inulin.
The invention creatively combines fructo-oligosaccharide, low-ester pectin and inulin as prebiotic components to be added into a bifidobacterium culture medium, and the three components are mutually matched to realize synergistic interaction, thereby having unexpected synergistic interaction effect on the aspects of promoting the proliferation of bifidobacterium and improving the yield of thalli. Compared with the commercial culture medium, the bifidobacterium culture medium provided by the invention has a remarkable proliferation promoting effect on bifidobacterium and has an important application value.
Preferably, the prebiotics comprise 1-5 parts of fructo-oligosaccharide, 1-5 parts of low ester pectin and 1-5 parts of inulin in parts by weight.
Specific examples of the above-mentioned 1 to 5 parts include 1 part, 1.2 parts, 1.5 parts, 1.7 parts, 2 parts, 2.2 parts, 2.5 parts, 2.7 parts, 3 parts, 3.2 parts, 3.5 parts, 3.7 parts, 4 parts, 4.2 parts, 4.5 parts, 4.7 parts, 5 parts and the like.
Preferably, the culture medium of bifidobacterium comprises 10 to 15g/L of carbon source, 30 to 45g/L of nitrogen source, 3 to 5g/L, L-0.1 to 1g/L of inorganic salt, 800.1 to 1g/L of tween and 1 to 5wt percent of prebiotics.
Specific values among the above 10-15g/L are, for example, 10g/L, 10.5g/L, 11g/L, 11.5g/L, 12g/L, 12.5g/L, 13g/L, 13.5g/L, 14g/L, 14.5g/L, 15g/L and the like.
Specific values among the above-mentioned 30 to 45g/L are, for example, 30g/L, 31g/L, 32g/L, 33g/L, 34g/L, 35g/L, 36g/L, 37g/L, 38g/L, 39g/L, 40g/L, 41g/L, 42g/L, 43g/L, 44g/L, 45g/L and the like.
Specific values among the above 3 to 5g/L are, for example, 3g/L, 3.2g/L, 3.4g/L, 3.6g/L, 3.8g/L, 4g/L, 4.2g/L, 4.4g/L, 4.6g/L, 4.8g/L, 5g/L and the like.
Specific values of the above-mentioned 0.1 to 1g/L are, for example, 0.1g/L, 0.2g/L, 0.3g/L, 0.4g/L, 0.5g/L, 0.6g/L, 0.7g/L, 0.8g/L, 0.9g/L, 1g/L and the like.
Specific values among the above 1 to 5 wt% are, for example, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt%, 5 wt%, etc.
Preferably, the carbon source comprises glucose.
Preferably, the nitrogen source comprises any one or combination of at least two of liver soaking powder, plant peptone, tryptone or yeast powder, such as combination of liver soaking powder and plant peptone, combination of plant peptone and tryptone, combination of tryptone and tryptone, and the like, and any other combination can be adopted, preferably tryptone.
In comparison with other choices, tryptone or tryptose peptone as a nitrogen source has a more significant effect of promoting the proliferation of bifidobacteria, and tryptone is preferred as a nitrogen source in the present invention from the viewpoint of cost reduction.
Preferably, the inorganic salt includes any one or a combination of at least two of sodium chloride, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, ferrous sulfate, manganese sulfate, magnesium sulfate and calcium chloride, for example, a combination of dipotassium hydrogen phosphate and potassium dihydrogen phosphate, a combination of manganese sulfate and magnesium sulfate, a combination of magnesium sulfate and calcium chloride, and the like, and any other combination may be adopted, and preferably a combination of sodium chloride, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, ferrous sulfate, manganese sulfate, magnesium sulfate and calcium chloride.
When the culture medium formula contains sodium chloride, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, ferrous sulfate, manganese sulfate, magnesium sulfate and calcium chloride, potassium, sodium, iron, magnesium, calcium, phosphorus, sulfur and other elements required for the growth of the bifidobacteria can be provided for the bifidobacteria, and the elements are very important for maintaining the activity of enzyme and regulating the osmotic pressure inside and outside the bacteria, so that the growth and proliferation of the bacteria are promoted.
Preferably, the inorganic salt comprises, by weight, 0.8-1.2 parts of sodium chloride, 0.8-1.2 parts of dipotassium hydrogen phosphate, 0.8-1.2 parts of monopotassium phosphate, 0.008-0.012 parts of ferrous sulfate, 0.002-0.008 parts of manganese sulfate, 0.2-0.8 parts of magnesium sulfate and 0.1-0.2 parts of calcium chloride.
Specific examples of the above-mentioned 0.8 to 1.2 parts include 0.8 part, 0.85 part, 0.9 part, 0.95 part, 1.0 part, 1.05 part, 1.1 part, 1.15 part, 1.2 part and the like.
Specific examples of the above-mentioned 0.008 to 0.012 parts include 0.008 parts, 0.0085 parts, 0.009 parts, 0.0095 parts, 0.010 parts, 0.0105 parts, 0.011 parts, 0.0115 parts, and 0.012 parts.
Specific examples of the above-mentioned 0.002 to 0.008 parts include 0.002 parts, 0.0025 parts, 0.003 parts, 0.0035 parts, 0.004 parts, 0.0045 parts, 0.005 parts, 0.0055 parts, 0.006 parts, 0.0065 parts, 0.007 parts, 0.0075 parts, and 0.008 parts.
Specific examples of the above-mentioned 0.2 to 0.8 parts include 0.2 part, 0.25 part, 0.3 part, 0.35 part, 0.4 part, 0.45 part, 0.5 part, 0.55 part, 0.6 part, 0.65 part, 0.7 part, 0.75 part, 0.8 part and the like.
Specific examples of the above-mentioned 0.1 to 0.2 parts include 0.1 part, 0.11 part, 0.12 part, 0.13 part, 0.14 part, 0.15 part, 0.16 part, 0.17 part, 0.18 part, 0.19 part, 0.2 part and the like.
Preferably, the pH of the culture medium for bifidobacteria is 6.0-7.0, e.g., 6.0, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7.0, etc.
When the pH of the medium is within the above range, growth and proliferation of Bifidobacterium are facilitated and the yield of Bifidobacterium obtained by the culture is higher.
In a second aspect, the present invention provides a method for culturing bifidobacteria, which comprises inoculating bifidobacteria to the culture medium for culture of bifidobacteria according to the first aspect.
Preferably, the temperature of the culture is 35-40 ℃, and the time of the culture is 20-30 h.
Specific values of the above-mentioned temperature range of 35-40 ℃ are, for example, 35 ℃, 35.5 ℃, 36 ℃, 36.5 ℃, 37 ℃, 37.5 ℃, 38 ℃, 38.5 ℃, 39 ℃, 39.5 ℃ and 40 ℃.
Specific numerical values of the above-mentioned 20 to 30h are, for example, 20h, 21h, 22h, 23h, 24h, 25h, 26h, 27h, 28h, 29h, 30h and the like.
Preferably, the bifidobacterium is inoculated in an amount of 1-3%, e.g. 1%, 1.2%, 1.4%, 1.6%, 1.8%, 2.0%, 2.2%, 2.4%, 2.6%, 2.8%, 3.0% etc.
Preferably, the culturing further comprises feeding, the feeding comprising supplementing a carbon source.
The invention creatively adds a material supplementing process in the culture process, and can obviously promote the bifidobacterium to fully utilize the nutrient components in the culture medium, thereby greatly improving the bacterium supplementing effect and increasing the thallus yield.
Preferably, the feeding is performed when the thalli grow to the middle or later period of logarithmic growth.
The time of feeding has certain influence on the bacterium increasing effect, and when the feeding operation is carried out in the middle or later period of logarithmic growth, the bacterium increasing effect is better, and the thallus yield is higher.
In a third aspect, the present invention provides a use of the method for culturing bifidobacterium according to the second aspect in the preparation of food, medicine or cosmetics.
The recitation of numerical ranges herein includes not only the above-recited values, but also any values between any of the above-recited numerical ranges not recited, and for brevity and clarity, is not intended to be exhaustive of the specific values encompassed within the range.
Compared with the prior art, the invention has the following beneficial effects:
the invention creatively adds the combination of inulin, fructo-oligosaccharide and low-ester pectin as prebiotic components into the culture medium of bifidobacterium, and the three components are mutually matched, thereby having synergistic effect, remarkable bacterium increasing effect and greatly improving the yield of the bifidobacterium. In addition, the selection of the nitrogen source has certain influence on the bacterium increasing effect, and the trypsin is used as the nitrogen source, so that the cost is lower, and the bacterium increasing effect is better than that of other nitrogen sources. In addition, the invention creatively adds a material supplementing process in the culture process, and can obviously promote the bifidobacterium to fully utilize the nutrient components in the culture medium, thereby greatly improving the bacterium increasing effect and increasing the thallus yield. In addition, the time of feeding has certain influence on the bacterium increasing effect, and the feeding operation is preferably carried out in the middle or later period of logarithmic growth. Compared with the commercial culture medium and the conventional culture method, the culture medium and the culture method for bifidobacterium provided by the invention obviously promote the proliferation of bifidobacterium, improve the yield of thalli and have important application value.
Drawings
FIG. 1 is a graph comparing the results for OD600 of examples 1, 2, 3, and 6, where example 1 is pH6.5, example 2 is pH 6.0, example 3 is pH 7.0, and example 6 is pH 5.0.
FIG. 2 is a graph comparing the results of OD600 cultured with different nitrogen sources. Among them, tryptone was used in example 1, liver extract powder was used in example 7, phytone was used in example 8, yeast powder was used in example 9, and tryptone was used in example 10.
Figure 3 is a graph comparing the results of OD600 for different prebiotic cultures. Wherein example 1 is a prebiotic combination, comparative example 4 is fructo-oligosaccharide, comparative example 5 is low ester pectin, and comparative example 6 is inulin.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following further describes the technical solution of the present invention with reference to the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
The following examples and comparative examples relate to fructooligosaccharides obtained from Zhengzhou Wanbo chemical products Co., Ltd., low ester pectins obtained from Shandong Bailong Chuanchuan biological science Co., Ltd., and inulin obtained from Chongqing Jiaowang agricultural development Co., Ltd. The bifidobacteria referred to in the following examples and comparative examples are Bifidobacterium infantis, purchased from the biological species Collection of Committee, Guangdong province, with the accession number CICC 6069.
Example 1
The present embodiment provides a method for culturing bifidobacterium, which comprises the following steps:
the formula of the culture medium is as follows: 36.0g/L of tryptone, 12.0g/L of glucose, 1.0g/L of sodium chloride, 1.0g/L of dipotassium phosphate, 1.0g/L of monopotassium phosphate, 0.01g/L of ferrous sulfate heptahydrate, 0.005g/L of manganese sulfate, 0.5g/L of magnesium sulfate, 0.15g/L, L-cysteine, 0.5g/L of calcium chloride, 800.5 g/L of tween, 1 wt% of inulin, 1 wt% of fructo-oligosaccharide, 1 wt% of low-ester pectin and water as a solvent.
(1) Preparing a culture medium according to a formula, adjusting the pH value to 6.5 by using NaOH aqueous solution, and sterilizing at the high temperature of 121 ℃ for 20min for later use.
(2) Taking out the bifidobacterium cryopreservation tube from a refrigerator at minus 80 ℃, freezing and thawing, sucking 1mL of seed solution, inoculating the seed solution into a seed activation culture medium (commercial MRS culture medium, specification 027312), and standing and culturing at 37 ℃ for 24h to obtain activated bifidobacterium.
(3) Inoculating the activated bifidobacteria obtained in the step (2) into the culture medium prepared in the step (1) in an inoculation amount of 2%, culturing at 37 ℃, supplementing 50 wt% of glucose aqueous solution when the bacteria grow to the middle logarithmic growth phase, wherein the supplementing speed is 50mL/h, and stirring (50rpm, 5min per 50 min) after supplementing. And co-culturing for 24 h.
Example 2
The present embodiment provides a method for culturing bifidobacterium, which comprises the following steps:
the formula of the culture medium is as follows: 32.0g/L of tryptone, 10.0g/L of glucose, 1.5g/L of sodium chloride, 1.5g/L of dipotassium phosphate, 1.5g/L of monopotassium phosphate, 0.02g/L of ferrous sulfate heptahydrate, 0.005g/L of manganese sulfate, 0.5g/L of magnesium sulfate, 0.10g/L, L g/L of calcium chloride-0.8 g/L of cysteine, 800.2 g/L of tween, 2 wt% of inulin, 0.5 wt% of fructo-oligosaccharide, 1 wt% of low-ester pectin and water as a solvent.
(1) Preparing culture medium according to the formula, adjusting pH to 6.0 with NaOH water solution, and sterilizing at 121 deg.C for 20 min.
(2) Taking out the bifidobacterium cryopreservation tube from a refrigerator at minus 80 ℃, sucking 1mL of seed liquid after freeze thawing, inoculating the seed liquid into a seed activation culture medium (commercial MRS culture medium, specification 027312), and standing and culturing at 37 ℃ for 24h to obtain activated bifidobacterium.
(3) Inoculating the activated bifidobacteria obtained in the step (2) into the culture medium prepared in the step (1) in an inoculation amount of 2%, culturing at 39 ℃, supplementing 50 wt% of glucose aqueous solution when the bacteria grow to the middle logarithmic growth phase, wherein the supplementing speed is 50mL/h, and stirring (50rpm, 5min per 50 min) after supplementing. And co-culturing for 24 h.
Example 3
The present embodiment provides a method for culturing bifidobacterium, which comprises the following steps:
the formula of the culture medium is as follows: 42.0g/L tryptone, 15.0g/L glucose, 0.8g/L sodium chloride, 1.1g/L dipotassium hydrogen phosphate, 1.1g/L potassium dihydrogen phosphate, 0.02g/L ferrous sulfate heptahydrate, 0.008g/L manganese sulfate, 0.8g/L magnesium sulfate, 0.2g/L, L-calcium chloride-0.3 g/L cysteine, 800.8 g/L tween, 0.8 wt% inulin, 1.2 wt% fructo-oligosaccharide, 1.2 wt% low ester pectin and water as solvent.
(1) Preparing culture medium according to the formula, adjusting pH to 7.0 with NaOH aqueous solution, and sterilizing at 121 deg.C for 20 min.
(2) Taking out the bifidobacterium cryopreservation tube from a refrigerator at minus 80 ℃, freezing and thawing, sucking 1mL of seed solution, inoculating the seed solution into a seed activation culture medium (commercial MRS culture medium, specification 027312), and standing and culturing at 37 ℃ for 24h to obtain activated bifidobacterium.
(3) Inoculating the activated bifidobacteria obtained in the step (2) into the culture medium prepared in the step (1) in an inoculation amount of 2%, culturing at 35 ℃, supplementing 50 wt% of glucose aqueous solution when the bacteria grow to the late logarithmic growth stage, wherein the supplementing speed is 50mL/h, and stirring (50rpm, 5min per 50 min) after supplementing. And co-culturing for 24 h.
Example 4
This example provides a method for culturing Bifidobacterium, which differs from example 1 only in that "a 50 wt% aqueous glucose solution is supplemented when the cells grow to the mid-logarithmic growth phase" is changed to "a 50 wt% aqueous glucose solution is supplemented when the cells grow to the pre-logarithmic growth phase" in step (3), otherwise refer to example 1.
Example 5
This example provides a method for culturing Bifidobacterium, which is different from example 1 only in that no feeding operation is performed in step (3), and an aqueous glucose solution in an amount equal to that added in the feeding operation of example 1 is added directly at the start of culturing, and otherwise refer to example 1.
Example 6
This example provides a method for culturing Bifidobacterium, which is different from example 1 only in that the pH of the culture medium is adjusted from "6.5" to "5.0" and the other components and contents are not changed.
The preparation process is as in example 1.
Example 7
This example provides a method for culturing Bifidobacterium, which differs from example 1 only in that the nitrogen source "tryptone" in the medium is replaced by an equal amount of "liver extract", and otherwise referred to in example 1.
Example 8
This example provides a method for culturing bifidobacteria, which differs from example 1 only in that the nitrogen source "tryptone" in the culture medium is replaced by an equal amount of "phytone", otherwise referred to in example 1.
Example 9
This example provides a method for culturing Bifidobacterium, which differs from example 1 only in that the nitrogen source "tryptone" in the medium is replaced by an equal amount of "yeast powder", and otherwise refers to example 1.
Example 10
This example provides a method for culturing Bifidobacterium, which differs from example 1 only in that the nitrogen source "tryptone" in the medium is replaced by the same amount of "tryptone", and otherwise referred to in example 1.
Comparative example 1
This comparative example provides a method for culturing bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced with "inulin 1.5 wt%, fructo-oligosaccharide 1.5 wt%" and otherwise referred to example 1.
Comparative example 2
This comparative example provides a method for culturing bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced with "inulin 1.5 wt%, low ester pectin 1.5 wt%" and otherwise referred to example 1.
Comparative example 3
This comparative example provides a method for the culture of bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced by "fructo-oligosaccharide 1.5 wt%, low ester pectin 1.5 wt%" and otherwise referred to example 1.
Comparative example 4
This comparative example provides a method for culturing bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced by "fructo-oligosaccharide 3 wt%", with reference to example 1.
Comparative example 5
This comparative example provides a method for the culture of bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced by "low ester pectin 3 wt%" and otherwise refer to example 1.
Comparative example 6
This comparative example provides a method for culturing bifidobacteria which differs from example 1 only in that the prebiotics "inulin 1 wt%, fructo-oligosaccharide 1 wt%, low ester pectin 1 wt%" in the culture medium are replaced with "inulin 3 wt%", with reference to example 1.
Comparative example 7
This comparative example provides a method for the culture of bifidobacteria which differs from example 1 only in that the culture medium lacks the prebiotics inulin, fructo-oligosaccharide and low ester pectin, the amount of which is made up with water, otherwise referred to in example 1.
Test example 1
Test groups were: examples 1 to 10, comparative examples 1 to 7.
The enrichment effect of bifidobacteria was evaluated by measuring the OD600 value in the bacterial liquid after the end of the culture.
After the culture was completed, the bacterial solution was centrifuged at 15000rpm, and the cells were collected, dried and weighed to obtain the yield of Bifidobacterium.
The results of the tests for each group are shown in table 1.
In order to make the result more visual, part of the data is arranged into a picture.
FIG. 1 is a graph comparing the results for OD600 of examples 1, 2, 3, and 6, where example 1 is pH6.5, example 2 is pH 6.0, example 3 is pH 7.0, and example 6 is pH 5.0.
FIG. 2 is a graph comparing the results of OD600 cultured with different nitrogen sources. Among them, tryptone was used in example 1, liver extract powder was used in example 7, phytone was used in example 8, yeast powder was used in example 9, and tryptone was used in example 10.
Figure 3 is a graph comparing the results of OD600 for different prebiotic cultures. Wherein example 1 is a prebiotic combination, comparative example 4 is fructo-oligosaccharide, comparative example 5 is low ester pectin, and comparative example 6 is inulin.
TABLE 1
The results show that: the methods for culturing bifidobacteria provided in examples 1 to 3 significantly promote the proliferation of bifidobacteria and produce higher yields of the resulting cells. The bacteria-increasing effect and the cell yield of the culture methods of comparative examples 1 to 7 are lower than those of example 1, which shows that the addition of the prebiotics into the culture medium plays a role in promoting the proliferation of the bifidobacteria, and when the combination of inulin, fructo-oligosaccharide and low-ester pectin is used as the prebiotic component, the bacteria-increasing effect is better than that of the combination of a single component or any two components, thereby proving the synergistic effect of the three components in promoting the proliferation of the bifidobacteria. The culture methods of examples 7 to 9 showed lower enrichment effects and cell yields than those of example 1, indicating that the selection of nitrogen source in the culture medium has a certain effect on the proliferation of bifidobacteria, and the present invention selected tryptone as nitrogen source, which showed better enrichment effects than those of liver extract, phytone and yeast powder. The bacteria-proliferating effect and the cell yield of the culture method of example 10 are relatively close to those of example 1, and it is explained that tryptone is used as the nitrogen source, and the bacterium-proliferating effect is close to that of tryptone, but tryptone is preferable as the nitrogen source in the present invention from the viewpoint of cost reduction. The culture method of example 6 showed lower growth enhancement effect and cell yield than example 1, indicating that the pH of the culture medium had a greater effect on the growth and proliferation of bifidobacteria, and that the culture medium had a pH of 6.0 to 7.0, which resulted in better growth enhancement effect and higher yield. The bacteria increasing effect and the thallus yield of the culture methods of the examples 4-5 are lower than those of the example 1, which shows that the supplement process is added in the culture process, so that the full utilization of the nutrient components in the culture medium by the bifidobacterium can be obviously promoted, the bacteria increasing effect is greatly improved, and the thallus yield is improved. In addition, the time of feeding has certain influence on the bacterium increasing effect, and the feeding operation is preferably carried out in the middle or later period of logarithmic growth. The bifidobacterium prepared by the corresponding culture method can be well applied to food, medicines or cosmetics.
The applicant states that the present invention is described by the above examples to describe a culture medium for bifidobacterium, a culture method and applications thereof, but the present invention is not limited to the above examples, i.e. it is not meant to be construed that the present invention is necessarily limited to the above examples. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
The preferred embodiments of the present invention have been described in detail, however, the present invention is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present invention within the technical idea of the present invention, and these simple modifications are within the protective scope of the present invention.
It should be noted that the various technical features described in the above embodiments can be combined in any suitable manner without contradiction, and the invention is not described in any way for the possible combinations in order to avoid unnecessary repetition.
Claims (10)
1. A culture medium for bifidobacterium, comprising a carbon source, a nitrogen source, inorganic salts and prebiotics;
the prebiotics include fructooligosaccharides, low ester pectins, and inulin.
2. A culture medium for bifidobacteria according to claim 1 wherein said prebiotic comprises, in parts by weight, 1-5 parts fructooligosaccharide, 1-5 parts pectin oligoester, and 1-5 parts inulin.
3. A culture medium for bifidobacteria according to claim 1 or 2, wherein said culture medium for bifidobacteria comprises, in concentration, 10 to 15g/L carbon source, 30 to 45g/L nitrogen source, 3 to 5g/L, L g/L inorganic salt, 0.1 to 1g/L cysteine, 800.1 to 1g/L tween and 1 to 5 wt.% prebiotics.
4. The culture medium of bifidobacteria according to any of claims 1-3, wherein said carbon source comprises glucose;
preferably, the nitrogen source comprises any one or a combination of at least two of liver soaking powder, plant peptone, tryptone or yeast powder, preferably tryptone.
5. The culture medium for bifidobacteria according to any of claims 1-4, wherein said inorganic salts comprise any one or a combination of at least two of sodium chloride, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, ferrous sulfate, manganese sulfate, magnesium sulfate, or calcium chloride, preferably a combination of sodium chloride, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, ferrous sulfate, manganese sulfate, magnesium sulfate, and calcium chloride;
preferably, the inorganic salt comprises, by weight, 0.8-1.2 parts of sodium chloride, 0.8-1.2 parts of dipotassium hydrogen phosphate, 0.8-1.2 parts of monopotassium phosphate, 0.008-0.012 parts of ferrous sulfate, 0.002-0.008 parts of manganese sulfate, 0.2-0.8 parts of magnesium sulfate and 0.1-0.2 parts of calcium chloride.
6. A culture medium for bifidobacteria according to any of claims 1 to 5, wherein said culture medium for bifidobacteria has a pH of from 6.0 to 7.0.
7. A method for culturing Bifidobacterium, which comprises inoculating Bifidobacterium medium as claimed in any of claims 1 to 6 and culturing.
8. The method for culturing Bifidobacterium according to claim 7, wherein the culturing is carried out at a temperature of 35 to 40 ℃ for 20 to 30 hours;
preferably, the bifidobacterium is inoculated in an amount of 1-3%.
9. The method for culturing Bifidobacterium according to claim 7 or 8, wherein the culturing further comprises feeding, the feeding comprising supplementing a carbon source;
preferably, the feeding is performed when the thalli grow to the middle or late stage of logarithmic growth.
10. Use of a method of culturing bifidobacteria according to any of claims 7-9 for the preparation of a food, pharmaceutical, or cosmetic product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210186252.2A CN114806920B (en) | 2022-02-28 | 2022-02-28 | Culture medium of bifidobacterium and culture method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210186252.2A CN114806920B (en) | 2022-02-28 | 2022-02-28 | Culture medium of bifidobacterium and culture method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114806920A true CN114806920A (en) | 2022-07-29 |
CN114806920B CN114806920B (en) | 2024-02-06 |
Family
ID=82528807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210186252.2A Active CN114806920B (en) | 2022-02-28 | 2022-02-28 | Culture medium of bifidobacterium and culture method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114806920B (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002240A2 (en) * | 2002-06-26 | 2004-01-08 | Danisco A/S | Use of hydrocolloids as prebiotic food ingredients and method of producing the same |
CN101058796A (en) * | 2007-04-25 | 2007-10-24 | 中国人民解放军第三军医大学第一附属医院 | Composite culture medium for bifidobacterium fermentation and preparation method thereof |
CN101715816A (en) * | 2009-11-18 | 2010-06-02 | 内蒙古伊利实业集团股份有限公司 | Fermented milk containing probiotics, production method thereof and application thereof |
US20120207712A1 (en) * | 2009-01-12 | 2012-08-16 | Pfizer Italia S.R.L. | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin |
CN105483059A (en) * | 2016-01-18 | 2016-04-13 | 王军 | Method for cultivating bifidobacteria through inulin |
CN105962378A (en) * | 2016-05-12 | 2016-09-28 | 李�浩 | Preparation method of active lactobacillus preparation containing hericium polysaccharides |
CN109329699A (en) * | 2018-09-25 | 2019-02-15 | 中北大学 | A kind of probiotics seabuckthorn fruit mud jelly and preparation method thereof |
CN109913523A (en) * | 2019-04-15 | 2019-06-21 | 江南大学 | A kind of culture medium of nitrogen source that screening suitable Bifidobacterium proliferation |
CN110055301A (en) * | 2019-05-06 | 2019-07-26 | 上海源本食品质量检验有限公司 | A method of the culture medium of detection Bifidobacterium and quickly detection count |
CN111876352A (en) * | 2020-07-28 | 2020-11-03 | 科兴生物制药股份有限公司 | Oxygen-resistant acid-resistant bifidobacterium infantis and screening method thereof |
-
2022
- 2022-02-28 CN CN202210186252.2A patent/CN114806920B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002240A2 (en) * | 2002-06-26 | 2004-01-08 | Danisco A/S | Use of hydrocolloids as prebiotic food ingredients and method of producing the same |
CN101058796A (en) * | 2007-04-25 | 2007-10-24 | 中国人民解放军第三军医大学第一附属医院 | Composite culture medium for bifidobacterium fermentation and preparation method thereof |
US20120207712A1 (en) * | 2009-01-12 | 2012-08-16 | Pfizer Italia S.R.L. | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin |
CN101715816A (en) * | 2009-11-18 | 2010-06-02 | 内蒙古伊利实业集团股份有限公司 | Fermented milk containing probiotics, production method thereof and application thereof |
CN105483059A (en) * | 2016-01-18 | 2016-04-13 | 王军 | Method for cultivating bifidobacteria through inulin |
CN105962378A (en) * | 2016-05-12 | 2016-09-28 | 李�浩 | Preparation method of active lactobacillus preparation containing hericium polysaccharides |
CN109329699A (en) * | 2018-09-25 | 2019-02-15 | 中北大学 | A kind of probiotics seabuckthorn fruit mud jelly and preparation method thereof |
CN109913523A (en) * | 2019-04-15 | 2019-06-21 | 江南大学 | A kind of culture medium of nitrogen source that screening suitable Bifidobacterium proliferation |
CN110055301A (en) * | 2019-05-06 | 2019-07-26 | 上海源本食品质量检验有限公司 | A method of the culture medium of detection Bifidobacterium and quickly detection count |
CN111876352A (en) * | 2020-07-28 | 2020-11-03 | 科兴生物制药股份有限公司 | Oxygen-resistant acid-resistant bifidobacterium infantis and screening method thereof |
Non-Patent Citations (4)
Title |
---|
何枫媛;葛武鹏;卫伟;朱红;刘锐;: "提高双歧杆菌活力的优化增菌发酵技术研究", 中国乳品工业, no. 05, pages 18 - 21 * |
周皓东;周艳;刘丽萍;夏刚强;韦策;张红漫;: "不同组成的果聚糖对两歧双歧杆菌体外生长的影响", 食品工业, no. 06, pages 201 - 204 * |
张国丽;彭瑶;魏露;余茜;敖晓琳;刘书亮;赵珂;: "植物乳杆菌SCP53生物膜的形成条件", 食品与发酵工业, no. 04, pages 12 - 19 * |
张泽生;张丽;吕晓玲;王霄然;卢亚莉;: "菊粉低聚果糖与蔗糖低聚果糖对双歧杆菌体外增殖的研究", 中国食品添加剂, no. 01, pages 44 - 48 * |
Also Published As
Publication number | Publication date |
---|---|
CN114806920B (en) | 2024-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106858066B (en) | Additive for synergistically promoting proliferation and colonization of intestinal probiotics and application method thereof | |
CN103173371B (en) | Production of saccharomyces cerevisiae and lactobacillus acidophilus composite microbe preparation used for feed | |
CN103798540A (en) | Multi-strain microorganism pig feed additive and production method thereof | |
CN111733091B (en) | Fermentation medium for bacillus subtilis, preparation method of fermentation medium and preparation method of bacillus subtilis preparation | |
CN103289910A (en) | Solid fermentation production method of bacillus coagulans | |
CN102919543B (en) | Method for preparing multifunctional ready-to-use fermented feed for animals by composite fermentation bacteria wet process | |
CN103932198A (en) | Preparation method for selenium-enriched glutathione beer yeast biological product by utilizing waste beer yeast | |
CN101967454A (en) | High-intensity culture method for lactobacilli | |
CN107217020A (en) | It is a kind of suitable for culture medium of lactobacillus acidophilus and preparation method thereof | |
CN102964152A (en) | Culture medium formula and preparation method of white beech mushroom liquid spawn | |
CN103976351A (en) | Health food capable of enhancing immunity and improving sleep and two-step fermentation preparation method thereof | |
CN115944665A (en) | Probiotic agent for improving intestinal flora balance and preparation method and application thereof | |
CN113046253A (en) | Culture method for improving heat resistance of kluyveromyces marxianus | |
CN101880703B (en) | Method for fermenting daptomycin by adding caprate | |
CN113397170B (en) | Application of marine prebiotics composition for regulating human intestinal flora | |
CN102964156A (en) | Culture medium formula and preparation method of Pleurotus nebrodensis liquid spawn | |
CN114806920B (en) | Culture medium of bifidobacterium and culture method and application thereof | |
CN105624071A (en) | Lactobacillus salivarius XJP2 and application thereof | |
CN104920791A (en) | A fermented fish meal with high digestibility rate and a preparation method thereof | |
CN102071165A (en) | Method for improving biomass of lactic acid bacteria at low pH by adding glutamic acid | |
CN101897385B (en) | Method for enhancing fermentation level of Bifidobacterium by utilizing lycopene | |
CN101638639A (en) | Method for preparing hyperoxide dismutase by fermenting shiraia bambusicola | |
CN112391317B (en) | Probiotic bacterial strain composition for producing cubilose acid and application | |
CN105969709A (en) | Recombinant escherichia coli strain and method for preparing lycopene by adopting same | |
CN103844054A (en) | Zinc-containing microecological feed additive for deer and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |